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Abstract. Analysis of the fate of a variety of newly
synthesized proteins in the secretory pathway has pro-
vided evidence for the existence of a novel protein
degradation system distinct from that of the lysosome.
Although current evidence suggests that proteins de-
graded by this system are localized to a pre-Golgi com-
partment before degradation, the site of proteolysis has
not been determined. A permeabilized cell system was
developed to examine whether degradation by this path-
way required transport out of the ER, and to define
the biochemical characteristics of this process. Studies
were performed on fibroblast cell lines expressing pro-
teins known to be sensitive substrates for this degrada-
tive process, such as the chimeric integral membrane
proteins, TacTCRoi and Tac-TORO. By immunofluores-
cence microscopy, these proteins were found to be lo-
calized to the ER. Treatment with cycloheximide re-
sulted in the progressive disappearance of intracellular
staining without change in the ER localization of the
chimeric proteins. Cells permeabilized with the pore-
ROTEIN degradation pathways are essential for the
maintenance of cellular homeostasis and participate
in a vast range of biological processes. Even though
virtually all cellular compartments contain proteolysic en-
zymes, the major sites of protein breakdown within eukary-
otic cells are the cytosol and lysosomes (see reviews by Bond
and Butler, 1987; Rechsteiner, 1987). Recent studies on the
fate of newly synthesized integral membrane and lumenal
proteins have provided evidence for the existence of a novel
degradative system in the early secretory pathway. A variety
of proteins that fail to be transported into the Golgi system
because of improper folding or lack of assembly into oligo-
mers have been found to be actively degraded by a process
referred to as "pre-Golgi degradation" or "ER degradation,"
(reviewed by Klausner and Sitia, 1990; Bonifacino and Lip-
pincott-Schwartz, 1991) .
Perhaps the most comprehensive description of the char-
acteristics of this degradative pathway has emerged from the
study of the multisubunit T cell antigen receptor (TCR)'
1. Abbreviations used in this paper: SLO, streptolysin O; TCR, Tcell anti-
gen receptor.
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forming toxin streptolysin O were able to degrade these
newly synthesized proteins. The protein degradation
seen in permeabilized cells was representative of that
seen in intact cells, as judged by the similar speed of
degradation, substrate selectivity, temperature depen-
dence, and involvement of free sulthydryl groups. Deg-
radation of these proteins in permeabilized cells took
place in the absence of transport between the ER and
the Golgi system. Moreover, degradation occurred in
the absence of added ATP or cytosol, and in the pres-
ence of apyrase, GTPyS, or EDTA; i.e., under condi-
tions which prevent transport of proteins out of the
ER. The efficiency and selectivity of degradation of
newly synthesized proteins were also conserved in an
isolated ER fraction. These data indicate that the ma-
chinery responsible for pre-Golgi degradation of newly
synthesized proteins exists within the ER itself, and
can operate independent of exogenously added ATP
and cytosolic factors.
complex (reviewed by Klausner et al., 1990). This receptor
is composed of at least seven chains (aßybet2), which must
be assembled in the ER for efficient transport to the cell sur-
face. Unassembled chains or partially assembled complexes
in most cases are selectively degraded (Lippincott-Schwartz
et al., 1988; Chen et al ., 1988; Bonifacino et al., 1989;
Wileman et al., 1990a,b) . Asparagine-linked carbohydrates
of the TCR chains degraded by this pathway remain sensitive
to endoglycosaminidase H (endo H), consistent with local-
ization to a compartment proximal to the medial-Golgi be-
fore degradation. A variety of inhibitors of lysosomal deg-
radation including acidotropic agents (i.e., chloroquine,
NH4Cl), specific protease inhibitors (i.e., leupeptin, E64),
or amino acid methyl esters all have little or no effect on pre-
Golgidegradation in vivo, suggesting that typical lysosomes
are not involved in this process. A distinctive characteristic
of the pre-Golgi degradation of TCR chains is its selectivity
with respect to substrates. Several studies have shown that
whereas some TCR chains (ca, ß, y, and S) can be rapidly
destroyed by this process, others (e and 0 remain stable for
long periods of time (Chen et al., 1988; Bonifacino et al.,
1989; Wileman et al., 1990a,b) . For some of the receptorchains, sensitivity to degradation by this pathway has been
found to be a result of the presence of specific structural in-
formation that determines their rapid degradation. Within
the ot and ß chains ofthe TCR, these determinants have been
localized to theirsingle membrane-spanning domains (Boni-
facino et al., 1990a,ó; Wileman et al ., 1990c).
A number of other unassembled subunits of oligomeric
complexes, resident ER proteins, abnormal and even seem-
ingly normal proteins have been shown to be degraded by a
pathway with similar characteristics to that described for
TCR chains. These include immunoglobulin heavy chains
(Sidman, 1981; Dulis et al., 1982; Sitia et al., 1987), the
H2a subunit ofthe asialoglycoprotein receptor (Amara et al.,
1989), acetylcholine receptor subunits (Merlie and Lind-
strom, 1983 ; Blount et al., 1990), 3-hydroxy-3 methylglu-
taryl coenzyme A reductase (Gil et al ., 1985; Jingami et al.,
1987; Chun et al ., 1990), acetylcholinesterase (Rotundo,
1988), apolipoprotein B (Davis et al., 1990; Sato et al.,
1990), a ß lactamase-« globin chimera (Stoller and Shields,
1989) and mutant forms of influenza hemagglutinin (Doyle
et al., 1986), the low density lipoprotein receptor (Esser and
Russell, 1988), ß-hexosaminidase (Lau and Neufeld, 1989),
and a,-antitrypsin (Le et al., 1990; Curiel et al ., 1990).
Mutant forms of the cystic fibrosis transmembrane conduc-
tance regulator found in most patients with this disease also
appear to be retained and degraded in a pre-Golgi compart-
ment (Cheng et al., 1990). Recent studies have suggested a
role for this degradative pathway in the processing of endog-
enous antigens for presentation to T cells (Weiss and Bogen,
1991). Despite the growing number of examples of this type
of degradation and its important role in the posttranslational
control ofprotein expression in physiological and pathologi-
cal states, this proteolytic pathway has been poorly charac-
terized .
An important issue that so far has remained unresolved
is the intracellular localization of the degradative system.
Biochemical and morphological evidence indicates that sub-
strates are localized to the ER before degradation (Lippin-
cott-Schwartz et al., 1988; Chen et al., 1988). However,
proteolysis could occur within the ER system itself or in
a compartment distal to the ER, such as the Golgi system.
The lack of specific inhibitors of the degradative process or
of transport between the ER and the Golgi system in intact
cells has precluded an unambiguous distinction between
these two possibilities. To examine a possible requirement
for transport between the ER and the Golgi system and to
further define the biochemical characteristics ofthe degrada-
tive process, we have used permeabilized cells in which
traffic between organelles is disrupted. Cells permeabilized
with the pore-forming toxin, streptolysin O (SLO), are
shown to degrade proteins retained in the ER with the same
general characteristics and selectivity displayed by intact
cells. Degradation in the permeabilized cells occurs in spite
ofa total absence oftransport between the ER and the Golgi
system, and is independent of exogenously added ATP or
cytosolic factors. Furthermore, agents known to disrupt
transport between the ER and the Golgi system as well as
other membrane transport pathways, such as apyrase,
EDTA, and GTPyS, all fail to inhibit protein degradation.
Taken together, these findings strongly suggest that degrada-
tion occurs within the ER system itself. This suggestion is
confirmed by the observation that newly synthesized trans-
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membrane proteins can be rapidly and selectively degraded
in vitro in a subcellular fraction enriched in rough ER.
Materials andMethods
RecombinantDNAs
Complementary DNA encoding the Tac antigen (a chain of the human
interleukin-2 receptor; Leonard et al., 1984) was the gift of Dr. Warren
Leonard (National Institute of Child Health and Human Development).
Construction of DNAs encoding the chimeric proteins Tac--TCRa, (hereon
referred to as Tac-TCRct) and Tac--TCR,8 has been described before
(Bonifacino etal., 19900; Manolios et al., 1990). All recombinantDNAs
were cloned into the expression plasmid CDM8 (Seed, 1987), modified as
previously described (Bonifacino et al., 1990a).
Transfections
The human fibroblast cellline Ml (agift ofDr. Eric O. Long, National Insti-
tutes of Allergy and Infectious Diseases) was maintained in DME sup-
plemented with 10% FBS and 0.15 mg/ml gentamicin (culture medium).
For generation ofstable transfectants, 3 x 105 cells plated on a 100-mm-
tissue culture dish one day before transfection were incubated overnight
(-12 h) with a calcium phosphate precipitate (Graham and Van der Eb,
1973; as modified by Gorman et al., 1983) containing 20,ug of a CDM8
plasmid and 2 pg of RSV.5(neo) (a gift of Dr. Eric O. Long) in 10 ml of
culture medium. After incubation, cells were rinsed once with PBS, treated
for 5 min with 10% DMSO in ice-cold PBS, rinsed once more with PBS,
and incubated for 24 h in fresh culture medium. The medium was then
replaced by fresh culture medium containing 0.5 mg/ml G418 (Gibco
Laboratories, Grand Island, NY). The selectivemediumwas changedevery
week. After 3-4 wk individual G418-resistant colonies were picked with
sterile pipette tips and transferred to 48-well plates. Positive clones were
identified by immunofluorescence microscopy, using anti-Tac antibodies
(see below), and expanded in regular culture medium containing 0.25
mg/ml G418.
Antibodies
Themouse mAb 7G7, directed against an extracellularepitope of the human
Tac antigen (Rubin et al., 1985a), was the kind gift of Dr. David Nelson
(National Cancer Institute). The rabbit polyclonal antibody R3134, raised
against purified human Tac (Sharon et al., 1986), and the mouse mAb anti-
Tac were generously provided by Dr. Warren Leonard. The mouse mAb
raised against human protein disulphide isomerase, HP13 (Kaetzel et al.,
1987), was the generous gift of Dr. Charlotte Kaetzel (Case Western Re-
serve University, Cleveland, OH). Rhodamine-labeled donkey anti-rabbit
and fluorescein-labeled donkey anti-mouseantibodies were purchased from
Jackson Inununoresearch Laboratories (West Grove, PA). These fluores-
cent antibodies had been passed through a solid-phase immunoadsorbent
gel to remove antibodies which cross-react with immunoglobulins from
other species, and were thus specifically prepared for double-labeling im-
munofluorescence experiments.
SpecificReagents
Reduced SLO was from Wellcome Diagnostics (Dartford, England).
Apyrase Grade VI, iodoacetamide, creatinephosphokinase, phosphocreatine,
and diamide were from Sigma Chemical Co. (St. Louis, MO). 2-deoxy-D-
glucose, and adenosine-5'-triphosphate were from Calbiochem-Behring
Corp. (La Jolla, CA). Leupeptin, aprotinin, hexokinase, and GTPyS were
fromBoehringer Mannheim Biochemicals (Indianapolis, IN). The lympho-
cytes from the enlarged lymph nodes of an MRL-lpr/lpr mouse were used
as a convenient source of cytosol, which was prepared by the method of
Beckers et al. (1987).
BiochemicalAssays
ATP was measured using a diagnostic kit (Sigma Chemical Co.), which
measured the conversion of ATP,3-phosphoglycerate, and NADH to glyc-
eraldehyde-3-P, NAD, and phosphate. Using the luminometer from Analyt-
ical Luminescence Laboratory (Monolight 2010; San Diego, CA), the de-
crease in absorbance at 350 run that resulted when NADH was oxidized to
NAD was measured as an index of the amount of ATP present.
1226Lactate dehydrogenase (LDH) was measured using a colorimetric diag-
nostic kit (Sigma Chemical Co.). LDH converted pyruvic acid to lactic
acid. An intensely colored phenylhydrazone was formed from residual py-
ruvic acid. The decrease in absorbance at 500 nm measured on a spectro-
photometer (LKB Instruments, Inc., Gaithersburg, MD) was inversely pro-
portional to LDH activity.
Metabolic Labeling
For the experiments on adherent cells depicted in Figs. 2 and 4, cells were
grown in 100-mm-tissue culture plates, washed three times in methio-
nine-free culture medium, and metabolically labeled by incubation in
methionine-free culture medium containing 250 pCi/ml of [35S]methio-
nine(Tran 35S-label; ICN Radiochemicals, Irvine, CA) for 15 min at 37°C.
For experiments in intact cells, cells were washed with DME at 4°C, and
placed in 5 ml regular culture medium at 37°C for the indicated chase
periods. Cells were then scraped and separated from the medium by cen-
trifugation for 5 min at400 g. Both the cells and medium were then frozen
at -70°C. For all subsequent experiments, cells grown attached to tissue
culture flasks were put into suspension by incubating at 37°C for 5 min in
Cal'- and Mgt*-free HBSS with 5 mM EDTA added. Cells were then
washed, and metabolicallylabeledas above. For experiments in intact cells,
cells were washed with DME at 4°C, and resuspended in 1 ml regular cul-
ture medium at 37°C for the indicated chase periods. After centrifugation
for 5 min at 400 g, the cell pellets were frozen at -70°C.
Cell Permeabilization
Permeabilization assay buffer consisted of 125 mM potassium acetate, 2.5
mM magnesium acetate, 10 mM glucose, 1 mM DTT, 25 mM Hepes,
buffered to pH 7.2 with 1 M potassium hydroxide. After metabolic labeling,
cells were washed once with permeabilization assay buffer at 0°C and in-
cubatedon ice for 15 min in 1.6 IU/ml SLO to allow binding ofthe polypep-
tide toxin. The excess toxin was washed off and the cells were incubated
in assay buffer at 37°C for 5 min to allow polymerization ofthe toxin and
pore formation. This protocol limits permeabilization to the plasma mem-
brane, while itpreserves the integrity ofintracellular organelle membranes
(Ahnert-Hilgeret al., 1989). For theexperiments onadherent cellsdepicted
in Figs. 2 and 4, the cells were chased in 5 ml ofassay buffer at 37°C. At
the end of the chase period, the cells were scraped and they were separated
from the assay buffer by centrifugation at 400 g for 5 min. The cells and
supernatants were then frozen at -70°C. In subsequent experiments, cells
in suspension were resuspended in permeabilization assay buffer and
incubated at 37°C. 100 Id aliquots were then taken after the indicated
chase periods and frozen at -70°C without separating cells from super-
natant.
Preparation ofa Rough ER Fraction
Subcellular fractionation was performed as described by Bole etal. (1986),
and all steps were carried out at 0°C. After metabolic labeling, cells were
washed in PBS and then washed and resuspended in 0.25 M sucrose in 5
mM Hepes buffered to pH 6.8. Cells were lysed in a nitrogen cavitation
bombby incubationat 50 psi for 15 min. After decompression thecellswere
disrupted with 20 strokes of a dounce homogenizer. Nuclei and intact cells
were removedby centrifugation at 800g for 10min. Thepostnuclear super-
natant was layered on top of a discontinuous sucrose gradient containing
1 ml:2 M, 3.4 m1:1.3 M, 3.4 ml:l M, and 2.75 m1:0.6 M sucrose in 5 mM
Hepes, pH 6.8, and centrifuged at 40,000 rpm in a rotor (model SW41;
Beckman Instruments, Inc., Palo Alto, CA) for 2 h. The band at the 1.3
M:2 M interface was diluted with 0.25 M sucrose, 5 mM Hepes, pH 6.8,
and centrifuged for 30 min at 50,000 rpm in a rotor (model 70.1/Ti; Beck-
man Instruments, Inc.). The pellet was resuspended in 400 pl permeabiliza-
tion assay buffer and incubated at 37°C. After the indicated chase periods,
100 pl aliquots were frozen at -70°C.
Immunoprecipitation, Electrophoresis,
andAutoradiography
Cells and supernatants were thawed at0°C, and solubilized in ice-coldlysis
buffer containing 0.5 % (wt/vol) Triton X-100, 300 mM NaCl, 50 mM Tris-
HCl (pH 7.6), and protease inhibitors, leupeptin (10,ug/ml), aprotinin (10
14g/ml), and iodoacetamide (10 mM) . Insoluble material was removed by
sedimentation at top speed in a microfuge (Beckman Instruments, Inc.) for
10 min at 4°C. The mAb, 7G7, adsorbed to protein A agarose (Bethesda
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Research Laboratories, Gaithersburg, MD) was then added to the superna-
tant for immunoprecipitation. After incubation for 1-2 h at 4°C, immuno-
precipitates were washed five times inice-coldsalinebuffer containing 0.1%
(wt/vol) Triton X-100 to remove unbound proteins, and then washed once
inice-coldPBS. Boundantigen was eluted from thebeads by boiling in SDS
sample buffercontaining3% ß-mercaptoethanol. Eluted proteins wereana-
lyzed by SDS-PAGE on 10% acrylamide gels, as described (Bonifacino et
al., 1989). Fluorograms were scanned used a densitometer (Ultrascan XL;
LKB Instruments Inc., Bromma, Sweden).
Immunofluorescence Microscopy
Cells were grown on 12-mm-round cover slips and fixed in 2% formalde-
hyde in PBS for 10 min at room temperature. Cells were washed in
PBS/0.1% BSA, and then incubated for I h in antibody in PBS with 0.1%
BSA and 0.1% saponin. After washing to remove unbound antibody, the
cells were incubated with fluorescently labeled secondantibody for 30 min.
After a final wash in PBS, the cover slips were mounted on glass slides in
Fluoromount G (Southern Biotechnology Associates, Birmingham, AL)
and viewed with a microscope (Carl Zeiss Inc., Thornwood, NY) equipped
with barrier filters to prevent crossover of fluorescein and rhodamine
fluorescence.
Results
Immunofluorescent Staining Localizes a Rapidly
Degraded Chimeric Protein to the ER
Degradation studies were performedon fibroblast cell lines
expressing thechimeric proteinTacTCRa, composed ofthe
lumenal domain of the Tac antigen and the transmembrane
and cytoplasmic domains of the TCR-a chain. This protein
was previously shown to be rapidly degraded within a pre-
Golgi compartment due to the presence of a specific deter-
minant fordegradation within the TCR-atransmembrane se-
quence (Bonifacino et al ., 1990a,ó). Immunofluorescence
microscopy studies showed complete colocalization of Tac-
TCR-ca (Fig. 1 a) with proteindisulphide isomerase (Fig. 1
b), a resident ER protein (Kaetzel et al., 1987). Both anti-
bodies stainedthe nuclearenvelope, as well as a fine reticu-
lar network extending throughout the cytoplasm, character-
istic of the ER. The Tac--TCRct chimeric protein thus
appeared to be confined to the ER system.
To follow the distribution of a cohort of Tac-TCRce from
synthesis to degradation, and thus to determine whether
degradation of Tac-TCRa was preceded by movement into
anothercellular compartment, cells were treated forvariable
periods before immunofluorescent staining with the protein
synthesis inhibitor cycloheximide at 10 Uglml. Consistent
with theobserved rate of degradation ofthe chimeric protein
in these cells (see Fig. 2), fluorescent staining of TacTCRa
was rapidly lost (Fig. 1, c, e, andg). At all time points before
its disappearance, however, staining of Tac-TCRci was
confined to a pattern typical of the ER. Recent studies have
shownthat certainproteins whichare localizedto the ER by
morphologicaltechniques canexit theER andaccumulate in
'a post-ER, intermediate compartment upon reduction in
temperature from 16 to 20°C (Lippincott-Schwartz et al.,
1990; Hsu et al., 1991). Treatment of cells expressing Tac-
TCR-a at these reduced temperatures, however, resulted in
no change in the immunofluorescent distribution of the chi-
meric protein (data not shown), suggesting that it is unable
to exit the ER following this route. The data obtained from
these immunofluorescent staining experiments suggested
that Tac-TCRa did not exit the ER system to be degraded.
1227Figure 2. Rapid degradation of Tac--TCRa, but not Tac, in intact and permeabilized cells . Ml cells transfected with 1äc or Tac-TCRa were
pulse labeled for 15 min at 37°C with P 5S]methionine . Cells were left intact or permeabilized with streptolysinO and chased for the indi-
cated time periods at 37°C in 5 ml medium or 5 ml assay buffer, respectively. Cells were removed from the plates, centrifuged at 2,000
rpm, and both pellets and supernatants were immunoprecipitated with the monoclonal anti Tac antibody, 7G7, before analysis bySDS-PAGE .
Degradation of Tac-TCRot in Pfrmeabilized Cells
To further examine whether transport out of the ER was re-
quired for degradation, a permeabilized cell system was de-
veloped . Fibroblasts stably transfected withDNA constructs
encoding different protein substrates were permeabilized
with SLO, as outlined in Materials and Methods . SLO is a
pore-forming toxin synthesized by 0-hemolytic group A
streptococci . When added to cells it produces large, stable
transmembrane pores with effective diameters exceeding 15
run, that allow exchange of substances between the cytosol
and the extracellular medium (Bhakdi and Tranum-Jensen,
1987) . To limit permeabilization to the plasma membrane,
cells were first incubated with SLO for 15 min at 4°C fol-
Figure 1. Immunofluorescent staining reveals thatTac--TCRa is confined to theER system . (A) Ml cells expressing 1àc--TCRa and permeabi-
lized with saponin were stained with 83134, a rabbitpolyclonal antibody to Tac (a), and HP13, a mousemAb to protein disulphide isomer-
ase (b), followed by rhodamine-labeled donkey anti-rabbit and fluorescein-labeled donkey anti-mouse antibodies . Specificity controls
showed no cross-reactivity of the second with the first antibodies . (B) Intact (c, e, and g) or SLO-permeabilized (d, f, and h) Ml cells
expressing Tac-TCRce were incubated at 37°C with 10 Ag/ml cycloheximide for 0 (c and d), 2 (e and f), or 4 (g and h) h . Cells were
then stained with 83134, followed by rhodamine-labeled donkey anti-rabbit antibody. Bar, 5 /Am .
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1229lowed by removal of the unbound toxin and an additional in-
cubation for 5 min at 37°C (Bhakdi and Tranum-Jensen,
1987 ; Ahnert-Hilger et al ., 1989) . The characteristics ofthe
cells permeabilized using this protocol are summarized in
Table I . Permeabilization allowed incorporation of the dye
Trypan blue (M = 960) in 100% of the cells, and resulted in
escape of most of the cytosol, as evidenced by a 95% loss
ofATP (M = 507), and a 95% loss oflactate dehydrogenase
(M = 135,000) . Mechanical permeabilization of cells has
been shown to cause cessation of export from the ER due to
the loss of ATP and cytosol (Beckers et al., 1987; Simons
and Virta, 1987) . To test whether SLO-permeabilized cells
were similarly unable to transport proteins from theER into
the cis-Golgi, we used the assay system devised by Beckers
et al . (1987), based on the acquisition of sensitivity to en-
doglycosaminidase D in cells deficient in x-acetyl glucosa-
minyl transferase. We found that in such a fibroblast cell line
(LEC 1) infected with the temperature-sensitive mutant of
the vesicular stomatitis virus (VSV) ts045, the newly synthe-
sized-G protein remained resistant to endoglycosaminidase
D at all times of chase at the permissive temperature, after
permeabilization with SLO (data not shown) . These obser-
vations were consistent with lack of export of newly synthe-
Figure 3. Loss of Tac--TCRa detected by immunoprecipitation with
a monoclonal and a polyclonal antibody after solubilization with
Triton X-100 or SDS . Ml cells expressing Tac-TCRa were pulse la-
beled for 15 min with [ASS]methionine . Cells were left intact or
permeabilized and chased for 0 (P) or 3 h at 37°C (Ch) . Proteins
were solubilized in lysis buffer containing 0.5% Triton X-100, be-
fore immunoprecipitation with themAb 7G7, orthe polyclonal anti-
body 83134; or solubilized in lysis buffer containing 0.5% Triton
X-100 and 1% SDS, before immunoprecipitation with 83134, as in-
dicated in the figure .
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The amount of ATP and lactate dehydrogenase was measured in an equal number of intact and permeabilized cells, as described in Materials and Methods .
' B-B units, Berger-Broida units .
sized proteins from the ER to the cis-Golgi in SLO-permea-
bilizedcells. Permeabilization oftheplasmamembrane, thus,
resulted in a cell with intact organelles, but no membrane
traffic between organelles .
Pulse-chase metabolic labeling experiments were per-
formed to further analyze the intracellular fate ofTac and the
chimeric proteins in intact and permeabilized cells . In intact
cells, Tac was gradually processed upon transport into the
Golgi system resulting in a shift in molecular mass from45
to 55 kD (Fig . 2 a) . The 45-kD form was sensitive to endo
H, whereas the 55-kD form was resistant to endo H, as its
carbohydrate side chains had been processed by Golgi en-
zymes (data not shown) . A 40-kD soluble, endo H-resistant
derivative of Tac, thought to arise by a proteolytic cleavage
at the plasma membrane (Rubin et al ., 1985b ; Robb and
Kutny, 1987), was slowly released into the medium (Fig . 2
c) . In contrast, Tac TCRct was rapidly degraded, with a half-
time of -10 min (Fig . 2 b) . There was no appearance of a
higher molecular weight, endo H-resistant form before
degradation (Fig . 2 b), and no immunoprecipitable material
was released into the medium (Fig . 2 d) .
In permeabilized cells, normal Tac remained as a 45-kD
precursor that was relatively stable (ti/2 = 8.6 h) (Fig. 2 e) .
As permeabilization resulted in lack of transport into the
Golgi system, neither the 55-kD mature form (Fig . 2 e) nor
the secreted form was seen (Fig . 2 g) . Thus, when normal
Tac was not allowed to exit the ER, by virtue of permeabili-
zation of the cells, it was not degraded . In contrast, Tac-
TCRa was rapidly degraded in permeabilized cells (Fig . 2
f) . During the chase period no processed form was detected
(Fig . 2f) and no immunoprecipitable Tac species was found
in the cell's supernatant (Fig . 2 h) .
On immunofluorescence microscopy of permeabilized
cells, staining of Tac-TCRot was typical of that of the ER
(Fig . 1 d) . Treatment of permeabilized cells with 10 jig/ml
cycloheximide revealed that staining of Tac-TCRa was rap-
idly lostand was localized exclusively to the ER at all time
points (Fig . 1, f and h) .
Figure 4. Kinetics of degra-
dation of TacTCR« and Tac-
TCRß in permeabilized cells.
Cells were metabolically la-
beled for 15 min at 37°C,
permeabilized and chased for
0-5h at-3-7°C . Detergent-solu-
bilized Tac species were im-
munoprecipitated with 7G7be-
fore analysis by SDS-PAGE .
The amount of each protein relative to time 0 was determined by
densitometric scanning of sutoradiograms.
TI.e (h)
Table I. Consequences ofPermeabilization of Cells with Streptolysin O
Intact Permeabilized
Incorporation of Trypan blue (M, = 960) 2 100
ATP (pmol) (M = 507) 21 1
Lactate dehydrogenase (B-B units)' (M, = 135,000) 959 50Loss of the chimeric protein by immunoprecipitation was
observed using two mAbs, 7G7 (Fig. 3) and antiTac, as well
as the rabbit polyclonal antibody, R3134, which recognizes
both native and denatured forms of the The antigen (Fig. 3) .
Furthermore, disappearance of TacTCRa was observed
when cell proteins were extracted with 1% SDS before im-
munoprecipitation with the polyclonal antibody R3134 (Fig.
3) . We thus concluded that the disappearance of Tac-TCRce
was not due to a conformational change causing loss ofanti-
body recognition, or development ofaggregates insoluble in
Triton X-100, but rather due to protein degradation.
In seven independent experiments, the half-life of Tac-
TCRa in permeabilized cells varied between 12 and 38 min
(Fig. 2 fand Fig. 4), with a mean of 26 min and a standard
error of 4 min. Another chimeric protein, Tac--TCM, com-
prised of the ectodomain of Tac and the transmembrane and
cytoplasmic domains of TCR,ß was also rapidly degraded
in SLO-permeabilized fibroblasts (t,rz = 37 min) (Fig. 4).
Thus, in permeabilized cells, Tac-TCRa and Tac-TCRO were
rapidly degraded, whereas normal Tac was only slowly
turned over, just as in intact cells. The similar selectivity
provided strong evidence that the processes involved in pre-
Golgidegradation were preserved in the permeabilized cells.
Effect ofTemperature on Degradation ofTacTCRoi in
Fermeabilized Cells
The pre-Golgi degradation of newly synthesized proteins in
intact cells has been shown to exhibit a characteristic tem-
perature dependence. Incubation of intact cells at tempera-
tures of 18°C or lower strongly inhibits the degradation of
the TCRci chain (Lippincott-Schwartz et al., 1988), the
TCR6 and CD3S chains (Wileman et al., 19906), and the
H2a subunit of the asialoglycoprotein receptor (Amara et
al., 1989) . Inhibition of degradation at these lowertempera-
tures serves as a useful trade mark for this degradative path-
way. To test whether the degradation of TacTCRa had a
similar temperature dependence in permeabilized cellsas in
intact cells, the stable transfectants were labeled with
[35S]methionine, permeabilized with SLO, and chased for
various periods over 2 h at different temperatures (37, 25, 20,
15, 10, and 4°C). As shown in Fig. 5, the degradation of Tac-
TCRa was significantly inhibited at 25 and 20°C, and com-
pletely inhibited at 15"C or lower temperatures, similar to
the previously described process in intact cells.
InvolvementofFree Sulthydryl Groups
in Pre-GolgiDegradation
The presence of a thiol reducing agent in the assay buffer
during the permeabilization and chaseperiods was a require-
ment for the occurrence of rapid degradation in permeabi-
lized cells. Degradation was slow in the absence of a reduc-
ing agent (Fig. 6 b). Degradation was more rapid in the
presence of 1 mM DTT (Fig. 6 a), than in the presence of
1 mM 6-mercaptoethanol (not shown), presumably as the
former is a more potent reducing agent. This observation
predicted that a membrane-permeable thiol oxidizing re-
agent should be able to inhibit the same degradation system
in intact cells. To test this prediction, we examined the effect
on degradation ofTac-TCRce ofa compound with these prop-
erties, "diamide" [Diazenedicarboxylic acidbis-(N,N-dimethyl-
amide)]. Addition of 1 mM diamide to pulse-labeled intact
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cells resulted in a dramatic inhibition of Tac-TCRa degrada-
tion (Fig. 6 d). Inhibition of degradation by diamide was re-
versed when cells were washed and resuspended in fresh
buffer containing 5 mM ß-mercaptoethanol (2ME) (Fig. 6
e) . Doses ofdiamide lowerthan 1 mM down to 0.25 mM par-
tially inhibited degradation (data not shown) . Diamide also
inhibited pre-Golgi degradation of another sensitive sub-
strate, CD4TCRce (Bonifacino et al., 19906), comprised of
the ectodomain of CD4 and the transmembrane and cyto-
plasmic domains of TCRce (data not shown) . These observa-
tions suggest that reduced sulthydryl groups are required for
rapid degradation both in intact and in permeabilized cells.
Exactly how they participate in the degradative process re-
mains to be established, although one interesting possibility
is that the enzymes involved include cysteine proteases.
RapidDegradation ofTac-TCRct IsIndependent
ofExogenouslyAddedATPorCytosol
Having thus established that rapid degradation could be seen
in permeabilized cells, with specificity and characteristics
similar to those seen in intact cells, we then set out to deter-
mine what the biochemical requirements for this degradative
process were. A number of transport events between mem-
brane-bound organelles have been shown to be dependent on
the presence of ATP and cytosolic factors (Beckers et al.,
1987; Melançon et al., 1987; Doms et al., 1987; Baker et
al., 1988; Blocket al., 1988). Weasked whether degradation
of Tac TCRci in Ml cellswas ATPdependent. The permeabi-
lization procedure itself resulted in loss of ATP, so that the
ATP content of permeabilized cells was <5% that of intact
cells. Depletion of ATP to levels of <0.2% by addition of
the phosphodiesterase, apyrase (50 U/ml), in the presence
of 0.4 mM CaC12, had no effect on the rate of degradation
of Tac--TCRa in permeabilized cells (Fig. 7 b). Similarly, ad-
dition of2 mg/ml hexokinase and 5 MM D-glucose to the as-
say buffer, which resulted in ATP levels of <0.5%, did not
affect the degradation of Tac-TCRci in permeabilized cells
(data not shown) . Thus, depletion of ATP on top of that
which resulted from the permeabilization procedure itself
did not further slow the rate of degradation. We then asked
whether addition ofATP would speed up the rate ofdegrada-
tion in permeabilized cells, perhaps to the somewhat faster
rate seen in intact cells. An ATPregenerating system, com-
prised of 1 mM ATP, 5 mM creatine phosphate, and 5 IU/ml
creatine phosphokinase, added to the assay buffer during the
chaseperiod, however, did not alter the rate of degradation
(Fig. 7 c). Similarly, addition of cytosol (0.6 mg/ml) aloneFigure 6. Requirement offree sulfhydryl groups in degradation ofTac-TCRu . Cells transfected with Tac-TCRa were metabolically labeled
for 15 min at 37°C . Permeabilized cells were incubated in permeabilization assay buffer either (a) with 1 mM DTT or (b) without DTT
for the chase periods indicated. Intact cells were incubated in (c) regular medium alone, (d) in the presence of 1 mM diamide for chase
periods up to 3 h, or (e) in the presence of 1 mM diamide for 1 h and washed and resuspended in medium with 5 mM2ME for a further
2 h . Proteins were solubilized and immunoprecipitated with 7G7 before analysis by SDS-PAGE .
(Fig . 7 d), or in combination with an ATPregenerating sys-
tem (Fig . 7 e) had no effect on the rate of degradation of Tac-
TCRa . The lack of a requirement for exogenously added
ATP and cytosol provided further evidence that degradation
was independent ofmembrane traffic out of the ER .
Reagents That BlockER to Golgi Transport DoNot
Inhibit Degradation ofTac-TCRa
Having established that factors necessary for ER to Golgi
transport were not required for rapid ER degradation, we
then asked whether reagents that blockER to Golgi transport
would inhibit degradation . Evidence from studies of semi-
intact cells has suggested that GTP plays an important role
in the regulation of transport between the ER and the Golgi
system (Beckers and Balch, 1988 ; Baker et al ., 1988 ;
Béckers et al., 1990) . Incubation with the nonhydrolyzable
guanine nucleotide analog, GTPyS, has been shown to in-
hibit transport in such a system (Beckers et al., 1990) . In
contrast to these effects on ER to Golgi transport, addition
of 10014M GTP-yS did not slow, but rather increased the rate
of degradation of TacTCRa (Fig. 8) . Cat+ ions have been
shown to be essential for the transport of proteins between
membrane-bound organelles, including ER to Golgi trans-
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port (Beckers and Balch, 1988 ; Beckers et al ., 1990) . In
spite of the Cal+ requirement for transport processes, how-
ever, addition of 5 mM EDTA, which chelates both Ca-
and Mgz+, or 5mM EGTA, which chelates Cal+ alone, did
not slow degradation (Fig. 8) . In keeping with a recent report
that depletion of cellular calcium in intact cells accelerates
pre-Golgi degradation (Wileman et al ., 1991), EDTA and
EGTA in our system reproducibly increased the rate of
degradation of Täc--TCRa .
RapidProteinDegradation in an Isolated
Rough ER Fraction
Our data suggested that in permeabilized cells with intact or-
ganelles, but with no traffic between organelles, degradation
of newly synthesized proteins proceeded as in intact cells,
and thus, pointed to the ER as the site of proteolysis. We
asked whether we could then demonstrate. protein degrada-
tion in isolated fractions of roughER . After metabolic label-
ing of cells for 15 min, a fraction containing rough ER was
isolatedby centrifugation of apostnuclear supernatant through
a discontinuous sucrosegradient, as described by Bole et al .,
(1986) . RoughER was collected at the 2 :1.3M sucrose inter-
face. Other organelles suchas smoothER, Golgi, lysosomes,
1232Figure 7 . Degradation of Tac--TCRci is independent ofATP and cytosol . Cells transfected with Tac-TCRci were metabolically labeled and
permeabilized . Cells were then incubated in thepermeabilizationassay buffer (a) alone, or with (b) apyrase, (c) anATPregenerating system,
(d) cytosol, or (e) an ATP-regenerating system and cytosol . Proteins were immunoprecipitated with 7G7 before analysis by SDS-PAGE .
(f) These autoradiograms were analyzed by densitometry, and the amount of each protein relative to time 0 was calculated . 9, control ;
11, apyrase ; o, ATP; 0, cytosol ; A, ATP + cytosol .
and plasma membrane are known to band at lower densities
in this type of gradient (Bole et al ., 1986 ; Saraste et al .,
1986) . The freshly isolated rough ER fraction, containing
-24% of the total labeled Tac-TCRce in the postnuclear su-
pernatant, was resuspended in assay buffer at 37°C, in the
absence ofaddedATP or cytosol . Rapid degradation of Tac-
TCRot was seen such that the protein had a half-life of -1l
min (Fig . 9) . In contrast, normal Tac was relatively stable
with a half-life of ti2 h (Fig . 9) . Thus, a fraction enriched
in rough ER was capable of degrading newly synthesized
proteins with a specificity similar to that observed in intact
and permeabilized cells .
Discussion
The identification of protein substrates that are especially
sensitive to pre-Golgi degradation, such assomeTCR chains
and the chimeric proteins used here, has greatly facilitated
the study of this pathway. The characteristic speed with
which these transmembrane proteins are degraded, as well
as the selectivity of this process, distinguish this type of
degradation from other, perhaps less specific, degradative
processes . By several measures, the degradation of newly
synthesized proteins observed in cells permeabilized with
SLO clearly corresponds to the same process originally de-
scribed in intact cells . First, chimeric proteins containing
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TCR transmembrane sequences are rapidly degraded with-
out production of detectable intermediates . Degradation of
these proteins in permeabilized cells seems to occur at a
slightly slower rate, as compared with intact cells Q112 =
12-38min vs . 10-20 min, respectively) . This difference may
be due tosome loss of proteases or other factors involved in
degradation during permeabilization . Second, as in intact
cells, normal Tac is degraded at a much slower rate, thus
confirming the selectivity ofthe process. Third, degradation
in permeabilized cells shows a similar temperature depen-
dence and is completely inhibited N15°C. Fourth, degrada-
tion in both systems involves critical reduced sulfhydryl
groups . To the extent to which they were studied, the effi-
ciency and selectivity ofdegradation were also conserved in
an isolated rough ER fraction .
The observation that permeabilized cells retain the ability
to degrade newly synthesized proteins allowed examination
of other characteristics of the degradative process . A fun-
damental question is where this degradation takes place .
Even though most ofthe morphological and biochemical evi-
dence was consistent with degradation occurring before
transport into the Golgi system, the inability to specifically
and completely interrupt transport between the ER and the
Golgi system in intact cells made this interpretation uncer-
tain . A complete block of transport between these two or-
ganelles can be achieved by permeabilization of cells
1233Figure 8. The rate of degrada-
tion of Tàc--TCRa is not re-
duced by reagents which in-
hibit ER to Golgi transport .
Cells were metabolically la-
beled, permeabilized, and
chased in buffer alone, or in
the presence of added 100AM
GTPyS, 5 mM EGTA, or
5 mM EDTA . Proteins were
immunoprecipitated with 7G7
and analyzedby SDS-PAGE . The amount ofprotein remaining rela-
tive to time 0 was calculated from densitometric scanning of au-
toradiograms . o, control ; e, EGTA ; w, EDTA; A, GTPyS.
(Beckers et al., 1987 ; Simons and Virta, 1987 ; Baker et al .,
1988) . Disruption ofthis transport pathway is due to loss of
ATP and cytosol, as addition of these results in reconstitu-
tion of transport (Beckers et al ., 1987 ; Baker et al., 1988) .
ATP and cytosol are probably required at several stages of
the pathway, including the formation of intermediate carrier
vesicles (Groesch et al ., 1990 ; Beckers et al., 1990) . Per-
meabilized cells have also been used to show that addition
of Ca- chelators and nonhydrolyzable GTP analogues
causes inhibition oftransport between the ER and the Golgi
system, suggesting a role for Cal+ and G proteins in this
process (Beckers and Balch, 1988 ; Beckers et al ., 1990) .
These requirements are in fact common to other processes
that involve traffic between membrane-bound organelles of
the secretory system, such as intra-Golgi transport (Melan-
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çon et al ., 1987), exocytosis (Salminen and Novick, 1987),
and endocytosis and recycling from the cell surface (Pod-
bilewicz and Mellman, 1990 ; Schmid and Carter, 1990) .
Our analysis of degradation of Tàc--TCRa in permeabilized
cells showed that this was independent of the presence or ab-
sence of ATP and cytosol in the medium and was not in-
hibited by Cal+ chelators or a nonhydrolyzable GTP ana-
logue, thus dissociating the occurrence of degradation from
transport between the ER and the Golgi system .
The existence of exit routes for newly synthesized proteins
other than through the Golgi system has not been definitively
established, but even if they did occur, they would most
likely involve membrane traffic with similar biochemical re-
quirements. Hence, this pathway for the degradation of
newly synthesized proteins appears to be confined to theER
system . This organellar system can be subdivided into sev-
eral contiguous subcompartments including the rough ER,
smooth ER, and nuclear envelope, each ofwhich has a some-
what different composition and function (Palade, 1975) .
Some macromolecules, such as precursors of chondroitin
sulfate proteoglycan and the associated link protein, are
localized to specialized regions of the ER (Vertel et al .,
1989) . Our results do not rule out the possibility that degra-
dation requires lateral movement from the site of synthesis
in the rough ER to another ER subcompartment . However,
the degradation in an isolated microsomal fraction of Tac-
TCRa synthesized during a short pulse suggests that the
ribosome-containingER itselfhas the ability to effect protein
breakdown .
Figure 9 Degradation of Tàc--TCRci in an isolated ER fraction . Cells transfected with Tàc or Thc--TCRu were metabolically labeled for
15 min, and disrupted by nitrogen cavitationand dounce homogenization . Postnuclear supernatants werecentrifugedthrough adiscontinuous
sucrose gradient. The rough ER fraction at the 1.3:2M interface was resuspended in assay buffer for the indicated time periods . Proteins
were immunoprecipitated with 7G7 and analyzed by SDS-PAGE . Densitometric scanning of these autoradiograms allowed measurement
of the amount of each protein remaining relative to time 0, which is plotted in the graph shown . a, Tàc; o, Thc--TCRa .Other proteolytic processes thought to occur within the
ER include the cleavage of signal peptides (Shelness et al .,
1988), the removal ofcarboxyl terminal extensions upon ad-
dition of glycolipid membrane anchors (Cross, 1990), and
the removal of accessorymolecules such as the T-cellrecep-
tor associated protein (Antusch et al., 1990). The occur-
rence of these proteolytic processing events, together with
the observation of rapid but selective protein breakdown
within the ER, all indicate that the ER must contain pro-
teases that perform these functions. Chymostatin-sensitive
endopeptidaseandzinc metalloendopeptidase activities have
been noted to be associated with dog pancreas microsome
membranes (Mumford et al ., 1980). Except for signal pepti-
dase, however, no other ER protease has been isolated and
fully characterized to date. The ability to observe rapid
degradation of certain protein substrates in isolated micro-
somes should serve as a starting point for the identification
and purification of ER proteases involved in this process.
The finding that degradation of TacTCRci occurs in per-
meabilized cells even after severe ATP depletion is impor-
tant notonly becauseit argues againstexit from the ER, but
also because it suggests that the degradative process itself
does not require ATP Other degradative pathways, notably
cytosolic protein breakdown, have been shown to involve
ATP-dependent proteinases (Etlinger and Goldberg, 1977;
Hough et al., 1987; Waxman et al., 1987). Degradation of
both exogenous and endogenous proteins in lysosomes has
also been found to require high levels of cellular ATP, al-
though in this case ATP is used not for thedegradative reac-
tion itself, but for the delivery of proteins to lysosomesand
forthemaintenanceoftheoptimalacidic environmentneces-
sary for lysosomal proteases. In spite of its independence
from exogenously addedATPin permeabilized cells andiso-
lated microsomes, however, combinations of metabolic poi-
sons such as 2-deoxy-D glucose plus either dinitrophenol or
sodium azide have been foundto slow down the degradation
of newly synthesized TacTCRce in intact cells by up to six-
fold (F. J. Stafford, unpublished observations) . These treat-
ments are effective at lowering intracellular ATP levels (to
-1%), buthave avariety of other effects which mightretard
ER degradation in intact cells, such as triggering of a stress
response, inhibition of protein synthesis, abnormal glycosy-
lation, changes in redox state and others (Ananthan et al.,
1986). Thus, partial inhibition by metabolic poisons in vivo
should not necessarily be interpreted as indicating that pre-
Golgi degradation is effected by ATPdependent proteinases.
A more isolated system such as permeabilized cells or
microsomes, should be regarded as a better setting to define
whether the degradative process itself needs ATP
Anotherinteresting characteristic revealed by thepermea-
bilized cell system is the possible involvement of free sulf-
hydrylsin degradation. Theobservation that reducing agents
were required for degradation in permeabilized cells pre-
dicted that cell-permeable thiol oxidizing reagents would be
effective inhibitors of pre-Golgi degradation in intact cells.
That this was thecase was demonstrated by the reversible in-
hibition effected by diamide. It is tempting to inferfrom this
observation that at leastsome enzymesinvolved in ER degra-
dation belong to theclassofcysteine proteases. In fact, many
intracellular proteinases that participate in cytosolic and ly-
sosomal pathways of proteinbreakdown belong to this class
(Bond and Butler, 1987). Cysteine proteases contain an es-
Stafford and Bonifacino The ER as a Site ofProtein Degradation
sential sulfhydryl group at their active site that formstran-
sient covalent complexes with their substrates (Polgar and
Halasz, 1982). However, thiol reagents are not specific for
active site sulfhyrysandcouldpotentially affect theactivity
of other classes of proteases or other putative components
ofthedegradative machinery. Amore accurate assessmentof
the potential role of cysteine proteases in ER degradation
will have to await thedevelopment of methodsto deliver ac-
tive site-specific cysteine reagents (i.e., peptide derivatives)
into the membrane-bound compartment where degradation
takes place.
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